Expanded Access for Abatacept
- Registration Number
- NCT05170672
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
This is an expanded access designed to provide access to abatacept for eligible participants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Local Institution - 0001
🇺🇸Austin, Texas, United States
Local Institution - 0002
🇧🇪Leuven, Vlaams-brabant, Belgium